2010年后皮肤科的主要治疗进展
摘要
随着科技的发展，涌现出了越来越多的治疗手段，为皮肤科难治性皮肤病的治疗带来了新的曙光，我们就近几年来出现的一些新的治疗手段进行综述如下。
出处
《中国中西医结合皮肤性病学杂志》
CAS
2011年第1期62-65,共4页
Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine
参考文献35
-
1Collins CE,Gavin AL,Migone TS,et al.B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus:disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels[J].Arthritis Res Ther,2006,8:R6.
-
2Zhang J,Roschke V,Baker KP,et al.Cutting edge:a role for B lymphocyte stimulator in systemic lupus erythematosus[J].J Immunol,2001,166:6-10.
-
3Cheema GS,Roschke V,Hilbert DM,et al.Elevated serum B lymphocyte stimulator levels in patients with systemic immunebased rheumatic diseases[J].Arthritis Rheum,2001,44:1313-1319.
-
4Wallace DJ,Stohl W,Furie RA,et al.A phase Ⅱ,randomized,double-blind,placebo-controlled,dose-ranging study of belimumab in patients with active systemic lupus erythematosus[J].Arthritis Rheum,2009,61:1168-1178.
-
5Robak E,Robak T.Monoclonal antibodies in the treatment of systemic lupus erythematosus[J].Curr Drug Targets,2009,10:26-37.
-
6D(o)rner T,Kaufmann J,Wegener WA,et al.Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus[J].Arthritis Res Ther,2006,8:R74.
-
7Mungo A,Priestley A,Nestorov I,et al.Safety,pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers[J].Eur J Clin Pharmacol,2007.63:647-656.
-
8Dall'Era M,Chakravarty E,Wallace D,et al.Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus:results of a multicenter,phase Ib,double-blind,placebo-controlled,dose-escalating trial[J].Arthritis Rheum,2007,56:4142-4150.
-
9Ponce R.Preclinical support for combination therapy in the treatment of autoimmunity with atacicept[J].Toxicol Pathol,2009,37:89-99.
-
10Kavanaugh A,McInnes I,Mease P,et al.Golimumab,a new human tumor necrosis factor alpha antibody,administered every four weeks as a subcutaneous injection in psoriatic arthritis:Twenty-four-week efficacy and safety results of a randomized,placebo-controlled study[J].Arthritis Rheum,2009,60:976-986.
-
1徐观辉,李建军.白癜风治疗新进展[J].皮肤性病诊疗学杂志,2010,17(1):75-77. 被引量：21
-
2赵乃英.小儿药疹90例临床分析[J].实用医技杂志,2010,17(11):1049-1050. 被引量：2
-
3刘建东,张国强.白癜风治疗的新进展[J].实用医学杂志,2008,24(7):1082-1084. 被引量：4
-
4朱芸,连石,张海萍,朱威.梅毒螺旋体主要膜蛋白的免疫学研究进展[J].实用皮肤病学杂志,2015,8(1):41-43.
-
5夏应魁.伴有发热的小儿药疹的诊断治疗[J].中国实用儿科杂志,2001,16(11):647-648. 被引量：4
-
6王刚.基础研究可圈可点 新型药物展现曙光——2016年皮肤病学进展回顾[J].中华医学信息导报,2017,32(4):12-13.
-
7薛艳利.瘙痒症的研究进展[J].河南化工,2010,27(4):81-81.
-
8常建民.皮肤科学-新世纪的挑战与希望[J].临床皮肤科杂志,2001,30(5):340-341. 被引量：3
-
9张荻,王旭.黄褐斑中西医治疗研究进展[J].辽宁中医药大学学报,2011,13(5):106-108. 被引量：11
-
10顾愹,杨涛,周智广.曙光在前--1型糖尿病临床免疫治疗探索之路[J].中国糖尿病杂志,2010,18(10):723-727. 被引量：1
